

HY-155356 · 5 mg
MedChemExpress · Cat: HY-155356
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/yn14.html
Description
YN14 is a KRASG12C proteolysis targeting chimera PROTAC . YN14 is highly potent and selective KRASG12C degrader and induces a stable KRASG12C: YN14: VHL ternary complex with low binding free energy ?G . YN14 has antiproliferative effects and significantly inhibits KRASG12C-mutant cancer cell growth. YN14 leads to tumor regression with tumor growth inhibition TGI% rates more than 100 % in the MIA PaCa-2 xenograft model.







